[Risk factors and choice of treatment method with uterine choriocarcinoma patients].
An analysis of the results of uterine choriocarcinoma treatment versus the degree of risk is presented. Chemotherapy alone was found to be sufficient in 70.2% of cases free of risk, as compared with only 31.2% in case of four and more factors. Application of chemotherapy alone proved, on the whole, to be more beneficial than that of surgery plus chemotherapy modality, as evidenced by the death rates of 13.8 +/- 3.4 and 32.5 +/- 5.4% (t = 2.9), respectively. Polychemotherapy of cases with 1-4 factors of risk or more gave significantly better results than monochemotherapy, regardless of the former being a sole treatment or a component of combined therapy.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002822:Choriocarcinoma / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007044:Hysterectomy; D011247:Pregnancy; D012306:Risk; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery
D000970:Antineoplastic Agents
Faktory riska i vybor metoda lecheniia bol'nykh khoriokartsinomoĭ matki.